Drugs / Agiocur Pregranules
last change May 2018 re-read 3 minutes ago

Agiocur Pregranules

Other / unclassified

Developed for
type 2 diabetes mellitus
Investigated by
Bukwang Pharmaceutical · ChunLab, Inc. · Samsung Medical Center

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03552991 Feb 2014 → Oct 2015 type 2 diabetes mellitus Samsung Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Agiocur Pregranules ClinicalTrials.gov intervention name — accepted as the source's own label NCT03552991 ↗
Modality Other / unclassified “Agiocur Pregranules' (dietary fiber) is administered for 28 days” NCT03552991 ↗